Crohn's Disease and Colitis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with Crohn's Disease
• People with currently active inflammation, shown by a symptom score of 5 or higher (HBI score) and either an elevated CRP blood marker or an elevated stool test result (calprotectin above 250 mcg/gr)
• People who are already starting one of the following medications as part of their normal medical care: Anti-TNFs, vedolizumab, ustekinumab, IL-23 inhibitors, JAK inhibitors, or S1P inhibitors

Who may not be able to join:

• People who are unable to give informed consent or complete the study requirements
• Women who are pregnant or breastfeeding
• People who are unwilling or unable to follow the study steps, including filling in questionnaires and wearing a watch while sleeping
• People diagnosed with ulcerative colitis or a form of inflammatory bowel disease that has not been clearly defined as Crohn's Disease
• People who have another sleep disorder, such as obstructive sleep apnea, overactive bladder, insomnia, shift work disorder, restless leg syndrome, periodic limb movement during sleep, or narcolepsy
• People currently using sleep medications, such as benzodiazepines or cannabis
• People who have had abdominal surgery in the past 4 weeks
• People with a serious condition affecting the heart, kidneys, or liver, as assessed by their doctor
• People who have an ileostomy (a surgically created opening in the abdomen) or short bowel syndrome

Important: Always verify eligibility with the trial site directly before applying.